Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / Speed Saves Lungs
Microbiology & Immunology Biochemistry and molecular biology Molecular Pathology Infectious Disease Clinical care

Speed Saves Lungs

Why rapid diagnostics matter during cold and flu season

By Kevin King 01/26/2026 Discussion 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders

Share

Clinical Report: Speed Saves Lungs

Overview

Pneumonia remains a significant global health threat, causing millions of cases and deaths annually. Rapid diagnostic technologies are essential for timely treatment and improved patient outcomes, particularly during peak cold and flu seasons.

Background

Pneumonia is a leading cause of morbidity and mortality worldwide, with a high incidence during colder months due to co-circulating respiratory viruses. Early detection and appropriate treatment are crucial to prevent severe complications such as respiratory distress and sepsis. The challenge lies in accurately distinguishing between bacterial and viral pneumonia to guide effective therapy and mitigate antibiotic resistance.

Data Highlights

No numerical data available in the source material.

Key Findings

Verify and adjust statistics to ensure they are accurately represented from the source.

Clinical Implications

Clinicians should prioritize the use of rapid diagnostic tools to differentiate between bacterial and viral pneumonia, especially during seasonal surges. This approach not only improves patient outcomes but also supports antimicrobial stewardship by reducing unnecessary antibiotic prescriptions.

Conclusion

The integration of rapid diagnostics in pneumonia management is vital for timely and effective patient care, particularly in vulnerable populations during peak seasons. Continued innovation in this field is essential to enhance clinical workflows and patient outcomes.

References

  1. American Thoracic Society, 2025 -- Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
  2. Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial - PubMed
  3. Clinical Research in Cardiology — Reply to Editorial Correspondence on Hopkins et al.: Impact of Surgical and FFP2/N95 Masks on Cardiopulmonary Exercise Performance: Discrepancies in Data Interpretation
  4. Pediatric Cardiology — Age-Appropriate Cardiopulmonary Function Assessment in Children Through Exercise Field Testing: A Novel Method
  5. Clinical Research in Cardiology — Impact of Face Masks on Athletic Performance and Cardiorespiratory Responses in Highly Trained Individuals
  6. conexiant — Low DLCO/SB Linked to Faster SSc Progression
  7. Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
  8. Duration of antibiotic treatment for community-acquired pneumonia - ScienceDirect
  9. Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial - PubMed

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kevin King

Kevin King is Senior Director of Scientific Affairs, QuidelOrtho

More Articles by Kevin King

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Redefining Diagnostic Reference Standards
Molecular Pathology
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Non-invasive Prostate Cancer Screening
Molecular Pathology
Non-invasive Prostate Cancer Screening

November 5, 2014

1 min read

Can SERS accurately detect the early stages of the most common male cancer?

Sequencing Access for All
Molecular Pathology
Sequencing Access for All

January 24, 2022

1 min read

An affordable genome sequencing pipeline for low- and middle-income countries

Improving Risk Stratification
Molecular Pathology
Improving Risk Stratification

February 3, 2022

1 min read

Two genes have been identified that may be linked to prostate cancer outcomes

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.